News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trigemina to Present at the 2013 International Headache Congress


6/26/2013 9:29:40 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON, June 26, 2013 (GLOBE NEWSWIRE) -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, will be presenting clinical data for its leading drug candidate, TI-001, intranasal oxytocin, for the treatment of chronic migraine at the 2013 International Headache Congress (IHC), hosted by the International Headache Society and American Headache Society, June 27th-30th, 2013, in Boston, Massachusetts.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Trigemina
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES